Search Results 191-200 of 19266 for autoimmune hepatitis
The purpose of this study is to assess a new drug to decrease liver fat in subjects with Non-Alcoholic Steatohepatitis or Non-Alcoholic Fatty Liver Disease.
The study will evaluate avatrombopag in the treatment of thrombocytopenia associated with liver disease prior to an elective procedure to reduce the need for ...
A Study to Evaluate Smartphone-based Digital Phenotyping for Relapse Prediction in Alcohol-associated Liver Disease · Overview · Participation eligibility.
The Genetics, Epigenetics and Metabolomics Core at Mayo Clinic runs the Cystic Kidney and Liver Disease Biobank for patient tissue samples.
Liver disease (eg, hepatitis B or C)—Use with caution. ... Autoimmune disorders (eg, Graves' disease, polymyositis, Guillain-Barré syndrome, and autoimmune ...
The purpose of this study is to assess the combined impact of post-processing methods that quantify potential biomarkers of chronic liver disease (AEF, fECS) ...
They collected skin fibroblasts, or cells, from people with liver disease and engineered bile duct cells derived from induced pluripotent stem cells. The ...
Autoimmune Disorders · Biomarker study in inflammatory bowl disease · Neuromyeltis optica · Mechanisms of pregnancy-driven tolerance in rheumatoid arthritis.
Mayo Clinic MELD Model calculator used to determine the survival probability of a patient with end stage liver disease, for use by medical professionals.
The stem cells will later be converted to liver cells and used to better understand liver disease and help develop treatments. Participation eligibility.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.